Molecular Partners AG (MOLN) — Cash Flow Reinvestment Rate
Molecular Partners AG (MOLN) has a Cash Flow Reinvestment Rate of 0.57x as of March 2022, reinvesting CHF93.61 Million (capex CHF380.00K plus investments CHF-93.23 Million) from operating cash flow of CHF163.56 Million. See MOLN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Molecular Partners AG Cash Flow Reinvestment Rate (2015–2022)
Historical reinvestment intensity for Molecular Partners AG across 2 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Molecular Partners AG.
Annual Cash Flow Reinvestment Rate for Molecular Partners AG (2015–2022)
Year-by-year capital reinvestment analysis for Molecular Partners AG. See financial agility of Molecular Partners AG to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.86x | CHF102.54 Million | CHF118.57 Million | CHF1.42 Million | ▲ +7.0% |
| 2015 | 0.81x | CHF21.41 Million | CHF26.50 Million | CHF1.39 Million | — |